 |
 |
 |
 |
 |
 |
Partners
Lab Partners
Dr. Eric Delwart:
Senior Investigator, Blood Systems Research Institute of San Francisco
Dr. Delwart’s interest is in identifying new disease causing viruses and reducing their negative impact by improving our understanding of their transmission, providing new diagnostic tools, identifying candidate immunogens and targets for the development of anti-virals.
Dr. Joseph DeRisi:
Professor, University of California, San Francisco
Dr. DeRisi’s lab exploits whole genome approaches to tackle problems in yeast molecular biology and human infectious disease. Dr. DeRisi is also a recognized expert in constructing and using a viral DNA microarray based system customized for the goal of detecting and differentiating between pathogens.
Dr. Tony Goldberg:
Professor, University of Wisconsin-Madison
Dr. Goldberg’s research focuses on the epidemiology and evolutionary ecology of infectious disease. Specifically, his laboratory employs epidemiological and molecular techniques to help reconstruct patterns by which pathogens spread within and between host populations, across complex landscapes, and over time.
Dr. Fabian Leendertz:
Senior Researcher, Robert Koch-Institut (RKI)
As lead of the African-German consortium at RKI, Dr. Leendertz research has focused on pathogens that afflict nonhuman primates. Through his efforts, we may come to better understand these pathogens and assess the risk on such pathogens entering into the human population.
Dr. Ian Lipkin:
Professor, Columbia University, Mailman School of Public Health
He is internationally recognized as an authority on the use of molecular biological methods for pathogen discovery and the role of immune and microbial factors in neurologic and neuropsychiatric diseases.
Dr. Martine Peeters:
Research Director, Département Sociétés et Santé, Institut de Recherché pour le Développement, University of Montpellier
Dr. Peeters is a recognized expert in the study of retroviruses. Much of Dr. Peeters work aims to better understand the circulation of viruses in human and nonhuman primate populations.
Dr. Oliver Pybus:
Royal Society University Research Fellow, University of Oxford
Dr. Pybus’ research aims to explain the evolutionary dynamics of pathogens, particularly viral infections of humans, including HIV/AIDS, the Hepatitis C Virus, and Influenza. His work seeks to understand how evolutionary and ecological processes combine and interact in natural populations.
Dr. Stephen Rich
Associate Professor, University of Massachusetts
The Rich lab focuses on the evolutionary dynamics of pathogen and host populations. They are particularly interested in the processes that have altered the genes and genomes of these organisms in a way that has facilitated their continued interaction.
Dr. Forest Rohwer:
Associate Professor, San Diego State University
Dr. Rohwer is a recognized expert in the study of microbial diversity, virus discovery, and a pioneer in the emerging field of metagenomics. His work is leading the way towards better understanding our microbial environment.
Dr. Peter Simmonds:
Professor, University of Edinburgh
Dr. Simmonds’ principal research interest and focus has been in the evolution and epidemiology of virus infections, and interactions with their hosts. This has led to a variety of research investigations ranging from evolutionary studies of virus variability and recombination, molecular epidemiology and investigations of viral pathogenesis and interactions of virus with host cell defenses.
Mr. William Switzer:
Non-HIV Surveillance Activity Leader, Laboratory Branch, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control
Mr. Switzer leads his branch in the study of simian retrovirus emergence among people who are exposed to primates during the course of their work and is a well-recognized authority in the field.
Dr Linfa Wang:
Senior Principal Research Scientist and Project Leader at Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Animal Health Laboratory
Dr Wang's laboratory is investigating the interaction of bats and viruses using a range of technologies. His continuing efforts may shed light on new viruses and reservoirs for human disease.
Lab Partners
Dr. Eric Delwart:
Senior Investigator, Blood Systems Research Institute of San Francisco
Dr. Delwart’s interest is in identifying new disease causing viruses and reducing their negative impact by improving our understanding of their transmission, providing new diagnostic tools, identifying candidate immunogens and targets for the development of anti-virals.
Dr. Joseph DeRisi:
Professor, University of California, San Francisco
Dr. DeRisi’s lab exploits whole genome approaches to tackle problems in yeast molecular biology and human infectious disease. Dr. DeRisi is also a recognized expert in constructing and using a viral DNA microarray based system customized for the goal of detecting and differentiating between pathogens.
Dr. Tony Goldberg:
Professor, University of Wisconsin-Madison
Dr. Goldberg’s research focuses on the epidemiology and evolutionary ecology of infectious disease. Specifically, his laboratory employs epidemiological and molecular techniques to help reconstruct patterns by which pathogens spread within and between host populations, across complex landscapes, and over time.
Dr. Fabian Leendertz:
Senior Researcher, Robert Koch-Institut (RKI)
As lead of the African-German consortium at RKI, Dr. Leendertz research has focused on pathogens that afflict nonhuman primates. Through his efforts, we may come to better understand these pathogens and assess the risk on such pathogens entering into the human population.
Dr. Ian Lipkin:
Professor, Columbia University, Mailman School of Public Health
He is internationally recognized as an authority on the use of molecular biological methods for pathogen discovery and the role of immune and microbial factors in neurologic and neuropsychiatric diseases.
Dr. Martine Peeters:
Research Director, Département Sociétés et Santé, Institut de Recherché pour le Développement, University of Montpellier
Dr. Peeters is a recognized expert in the study of retroviruses. Much of Dr. Peeters work aims to better understand the circulation of viruses in human and nonhuman primate populations.
Dr. Oliver Pybus:
Royal Society University Research Fellow, University of Oxford
Dr. Pybus’ research aims to explain the evolutionary dynamics of pathogens, particularly viral infections of humans, including HIV/AIDS, the Hepatitis C Virus, and Influenza. His work seeks to understand how evolutionary and ecological processes combine and interact in natural populations.
Dr. Stephen Rich
Associate Professor, University of Massachusetts
The Rich lab focuses on the evolutionary dynamics of pathogen and host populations. They are particularly interested in the processes that have altered the genes and genomes of these organisms in a way that has facilitated their continued interaction.
Dr. Forest Rohwer:
Associate Professor, San Diego State University
Dr. Rohwer is a recognized expert in the study of microbial diversity, virus discovery, and a pioneer in the emerging field of metagenomics. His work is leading the way towards better understanding our microbial environment.
Dr. Peter Simmonds:
Professor, University of Edinburgh
Dr. Simmonds’ principal research interest and focus has been in the evolution and epidemiology of virus infections, and interactions with their hosts. This has led to a variety of research investigations ranging from evolutionary studies of virus variability and recombination, molecular epidemiology and investigations of viral pathogenesis and interactions of virus with host cell defenses.
Mr. William Switzer:
Non-HIV Surveillance Activity Leader, Laboratory Branch, Division of HIV/AIDS Prevention, NCHSTP, Centers for Disease Control
Mr. Switzer leads his branch in the study of simian retrovirus emergence among people who are exposed to primates during the course of their work and is a well-recognized authority in the field.
Dr Linfa Wang:
Senior Principal Research Scientist and Project Leader at Commonwealth Scientific and Industrial Research Organisation (CSIRO) Australian Animal Health Laboratory
Dr Wang's laboratory is investigating the interaction of bats and viruses using a range of technologies. His continuing efforts may shed light on new viruses and reservoirs for human disease.